President Donald Trump boldy proclaimed that new federal legislation he signed will save hundreds of thousands of lives. It’s a bold assertion(what would you expect), but is it remotely true? The answer is no, according to Dr. Alison Bateman-House, an Assistant Professor in the Division of Medical Ethics at New York University. The legislation, already in place in a vast majority of states, lets terminally ill patients do an end around the Food & Drug Administration in their search for life saving medicines and therapies. So why would this notion be so problematic, when on the surface it sounds so good? We explore in this podcast.
Podcast: Play in new window | Download